Previous 10 | Next 10 |
ViewRay, Inc. (VRAY) Q4 2021 Earnings Conference Call February 24, 2022 04:30 PM ET Company Participants Matt Harrison - Director, Investor Relations Scott Drake - President and Chief Executive Officer Zach Stassen - Chief Financial Officer Paul Strong - Vice President, Clinical Affairs Confe...
The following slide deck was published by ViewRay, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: ViewRay, Inc. 2021 Q4 - Results - Earnings Call Presentation
ViewRay press release (NASDAQ:VRAY): Q4 GAAP EPS of -$0.16 misses by $0.02. Revenue of $20.4M (+10.5% Y/Y) beats by $0.67M. ViewRay had total cash and cash equivalents of $218.3 million at December 31, 2021. For the full year 2022, ViewRay anticipates total revenue to be in the range of ...
ViewRay Announces Fourth Quarter and Full Year 2021 Results PR Newswire CLEVELAND , Feb. 24, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the fourth quarter and full fiscal year ended December 31, 20...
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer Poster on Interim Trial Data Comparing MRI-Guided vs. CT-Guided SBRT Toxicities for Prostate Cancer to ...
ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire CLEVELAND , Feb. 10, 20...
ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022 PR Newswire CLEVELAND , Feb. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the ...
University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services MRIdian will be the First MRI-guided Radiation Therapy System at Krukenberg Cancer Center PR Newswire CLEVELAND , Feb. 9, 2022 /P...
ViewRay® to Participate in the B. Riley Securities Oncology Conference PR Newswire CLEVELAND , Jan. 25, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the B. Riley Securities Oncology Conference. Scot...
ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results PR Newswire CLEVELAND , Jan. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year e...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...